603 related articles for article (PubMed ID: 20805624)
1. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
Bhatt DL; Eagle KA; Ohman EM; Hirsch AT; Goto S; Mahoney EM; Wilson PW; Alberts MJ; D'Agostino R; Liau CS; Mas JL; Röther J; Smith SC; Salette G; Contant CF; Massaro JM; Steg PG;
JAMA; 2010 Sep; 304(12):1350-7. PubMed ID: 20805624
[TBL] [Abstract][Full Text] [Related]
2. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
[TBL] [Abstract][Full Text] [Related]
3. One-year cardiovascular event rates in outpatients with atherothrombosis.
Steg PG; Bhatt DL; Wilson PW; D'Agostino R; Ohman EM; Röther J; Liau CS; Hirsch AT; Mas JL; Ikeda Y; Pencina MJ; Goto S;
JAMA; 2007 Mar; 297(11):1197-206. PubMed ID: 17374814
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis.
Udell JA; Steg PG; Scirica BM; Eagle KA; Ohman EM; Goto S; Alsheikh-Ali AA; Porath A; Corbalan R; Umez-Eronini AA; Hoffman EB; Wilson PW; Bhatt DL;
Eur J Prev Cardiol; 2014 Dec; 21(12):1531-40. PubMed ID: 23918840
[TBL] [Abstract][Full Text] [Related]
5. Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis.
Boden WE; Cherr GS; Eagle KA; Cannon CP; Califf RM; Hirsch AT; Alberts MJ; Criqui M; Creager MA; Massaro JM; D'Agostino RB; Steg PG; Bhatt DL;
Crit Pathw Cardiol; 2010 Sep; 9(3):116-25. PubMed ID: 20802264
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
[TBL] [Abstract][Full Text] [Related]
7. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
Baumgartner I; Hirsch AT; Abola MT; Cacoub PP; Poldermans D; Steg PG; Creager MA; Bhatt DL;
J Vasc Surg; 2008 Oct; 48(4):808-14. PubMed ID: 18639426
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
Krempf M; Parhofer KG; Steg PG; Bhatt DL; Ohman EM; Röther J; Goto S; Pasquet B; Wilson PW;
Am J Cardiol; 2010 Mar; 105(5):667-71. PubMed ID: 20185014
[TBL] [Abstract][Full Text] [Related]
10. Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
Cavender MA; Steg PG; Smith SC; Eagle K; Ohman EM; Goto S; Kuder J; Im K; Wilson PW; Bhatt DL;
Circulation; 2015 Sep; 132(10):923-31. PubMed ID: 26152709
[TBL] [Abstract][Full Text] [Related]
11. Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
Eisen A; Bhatt DL; Steg PG; Eagle KA; Goto S; Guo J; Smith SC; Ohman EM; Scirica BM;
J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27680665
[TBL] [Abstract][Full Text] [Related]
12. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.
Bhatt DL; Steg PG; Ohman EM; Hirsch AT; Ikeda Y; Mas JL; Goto S; Liau CS; Richard AJ; Röther J; Wilson PW;
JAMA; 2006 Jan; 295(2):180-9. PubMed ID: 16403930
[TBL] [Abstract][Full Text] [Related]
13. Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis.
Sirimarco G; Amarenco P; Labreuche J; Touboul PJ; Alberts M; Goto S; Rother J; Mas JL; Bhatt DL; Steg PG;
Stroke; 2013 Feb; 44(2):373-9. PubMed ID: 23306325
[TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular complications at 1-year of follow-up in patients with atherothrombosis. On behalf of Spain's REACH Registry].
Suárez C; Castillo J; Esmatjes E; Sala J; Cairols M; Montoto C; Barberá G;
Med Clin (Barc); 2009 Apr; 132(14):537-44. PubMed ID: 19393390
[TBL] [Abstract][Full Text] [Related]
15. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry.
Weimar C; Diener HC; Alberts MJ; Steg PG; Bhatt DL; Wilson PW; Mas JL; Röther J;
Stroke; 2009 Feb; 40(2):350-4. PubMed ID: 19023098
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis.
Giustino G; Baber U; Salianski O; Sartori S; Stone GW; Leon MB; Aquino M; Stefanini GG; Steg PG; Windecker S; O' Donoghue M; Wijns W; Serruys PW; Valgimigli M; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari D; Von Birgelen C; Dangas GD; Cha JY; Galatius S; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Genereux P; Chieffo A; Mehran R
Circ Cardiovasc Interv; 2016 Jan; 9(1):e002995. PubMed ID: 26747850
[TBL] [Abstract][Full Text] [Related]
17. A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease.
Ducrocq G; Amarenco P; Labreuche J; Alberts MJ; Mas JL; Ohman EM; Goto S; Lavallée P; Bhatt DL; Steg PG
Circulation; 2013 Feb; 127(6):730-8. PubMed ID: 23277306
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry.
Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Steg PG; Cannon CP; Brennan DM; Bhatt DL;
Crit Pathw Cardiol; 2009 Jun; 8(2):91-7. PubMed ID: 19417637
[TBL] [Abstract][Full Text] [Related]
19. Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry.
Suárez C; Zeymer U; Limbourg T; Baumgartner I; Cacoub P; Poldermans D; Röther J; Bhatt DL; Steg PG;
Vasc Med; 2010 Aug; 15(4):259-65. PubMed ID: 20724374
[TBL] [Abstract][Full Text] [Related]
20. Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry.
Ruff CT; Bhatt DL; Steg PG; Gersh BJ; Alberts MJ; Hoffman EB; Ohman EM; Eagle KA; Lip GY; Goto S;
Int J Cardiol; 2014 Jan; 170(3):413-8. PubMed ID: 24321327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
